{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:45:36Z","timestamp":1764251136049},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Targeted inactivation of p27kip1 was sufficient for intestinal tumor formation in mice, but this was strictly a function of diet: tumors formed in p27+\/\u2212 or p27\u2212\/\u2212 mice fed control AIN-76A diet and were increased by a western-style diet but did not develop in mice fed standard chow diet. When crossed with the Apc1638N+\/\u2212 mouse, Apc+\/\u2212,p27+\/\u2212 or Apc+\/\u2212,p27\u2212\/\u2212 mice not only formed twice as many tumors than the sum of the tumors from mutation at either locus alone, but on AIN76A diet also developed intestinal intussusception, a tumor-associated pathology in patients leading to intestinal blockage that has not been reported for intestinal cancer in mouse models. Moreover, the frequency of intussusception was increased when the compound mutant mice were maintained on the western diet, leading to early death. Despite this more aggressive tumor phenotype generated by inactivation of p27 than by inactivation of another cyclin-dependent kinase inhibitor, p21WAF1\/cip1, the nonsteroidal anti-inflammatory drug sulindac was still effective in inhibiting intestinal tumor formation in Apc+\/\u2212,p27+\/\u2212 or Apc+\/\u2212,p27\u2212\/\u2212 mice, which contrasts with the abrogation of the effects of sulindac in Apc+\/\u2212,p21+\/\u2212 or Apc+\/\u2212,p21\u2212\/\u2212 mice, indicating that p27 is not necessary for tumor inhibition by sulindac. Furthermore, tumor inhibition by sulindac was linked to the induction of p21 expression by the drug, regardless of p27 status, leading to suppression of cell proliferation and promotion of cell differentiation and apoptosis in the intestinal mucosa.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-2113","type":"journal-article","created":{"date-parts":[[2005,10,17]],"date-time":"2005-10-17T16:32:52Z","timestamp":1129566772000},"page":"9363-9368","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["<i>p27kip1<\/i> in Intestinal Tumorigenesis and Chemoprevention in the Mouse"],"prefix":"10.1158","volume":"65","author":[{"given":"WanCai","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bancroft","sequence":"additional","affiliation":[{"name":"Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard H.","family":"Augenlicht","sequence":"additional","affiliation":[{"name":"Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2005,10,17]]},"reference":[{"key":"2022061621193711300_B1","unstructured":"Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res\u20082000; 60: 3689\u201395."},{"key":"2022061621193711300_B2","doi-asserted-by":"crossref","unstructured":"Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev\u20081999; 13: 1501\u201312.","DOI":"10.1101\/gad.13.12.1501"},{"key":"2022061621193711300_B3","doi-asserted-by":"crossref","unstructured":"Deschenes C, Vezina A, Beaulieu JF, Rivard N. Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology\u20082001; 120: 423\u201338.","DOI":"10.1053\/gast.2001.21199"},{"key":"2022061621193711300_B4","doi-asserted-by":"crossref","unstructured":"Cariou S, Catzavelos C, Slingerland JM. Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1. Breast Cancer Res Treat\u20081998; 52: 29\u201341.","DOI":"10.1023\/A:1006154900130"},{"key":"2022061621193711300_B5","doi-asserted-by":"crossref","unstructured":"Lloyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol\u20081999; 154: 313\u201323.","DOI":"10.1016\/S0002-9440(10)65277-7"},{"key":"2022061621193711300_B6","doi-asserted-by":"crossref","unstructured":"Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol\u20081998; 153: 681\u20137.","DOI":"10.1016\/S0002-9440(10)65610-6"},{"key":"2022061621193711300_B7","doi-asserted-by":"crossref","unstructured":"Tsihlias J, Kapusta L, Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med\u20081999; 50: 401\u201323.","DOI":"10.1146\/annurev.med.50.1.401"},{"key":"2022061621193711300_B8","doi-asserted-by":"crossref","unstructured":"Yao J, Eu KW, Seow-Choen F, Cheah PY. Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas. Int J Cancer\u20082000; 89: 213\u20136.","DOI":"10.1002\/1097-0215(20000520)89:3<213::AID-IJC1>3.0.CO;2-L"},{"key":"2022061621193711300_B9","doi-asserted-by":"crossref","unstructured":"Zhang H, Sun XF. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. Int J Oncol\u20082001; 19: 49\u201352.","DOI":"10.3892\/ijo.19.1.49"},{"key":"2022061621193711300_B10","doi-asserted-by":"crossref","unstructured":"Kagawa Y, Yoshida K, Hirai T, Toge T. Significance of the expression of p27Kip1 in esophageal squamous cell carcinomas. Dis Esophagus\u20082000; 13: 179\u201384.","DOI":"10.1046\/j.1442-2050.2000.00096.x"},{"key":"2022061621193711300_B11","doi-asserted-by":"crossref","unstructured":"Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell\u20081996; 85: 721\u201332.","DOI":"10.1016\/S0092-8674(00)81238-6"},{"key":"2022061621193711300_B12","doi-asserted-by":"crossref","unstructured":"Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell\u20081996; 85: 707\u201320.","DOI":"10.1016\/S0092-8674(00)81237-4"},{"key":"2022061621193711300_B13","unstructured":"Yang WC, Bancroft L, Nicholas C, Lozonschi I, Augenlicht LH. Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. Cancer Res\u20082003; 63: 4990\u20136."},{"key":"2022061621193711300_B14","unstructured":"Philipp-Staheli J, Kim KH, Payne SR, et al. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell\u20082002; 1: 355\u201368."},{"key":"2022061621193711300_B15","doi-asserted-by":"crossref","unstructured":"Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med\u20081993; 328: 1313\u20136.","DOI":"10.1056\/NEJM199305063281805"},{"key":"2022061621193711300_B16","doi-asserted-by":"crossref","unstructured":"Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg\u20081993; 80: 1618\u20139.","DOI":"10.1002\/bjs.1800801244"},{"key":"2022061621193711300_B17","unstructured":"Yang WC, Velcich A, Mariadason J, et al. p21(WAF1\/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res\u20082001; 61: 6297\u2013302."},{"key":"2022061621193711300_B18","unstructured":"Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res\u20081996; 56: 2556\u201360."},{"key":"2022061621193711300_B19","doi-asserted-by":"crossref","unstructured":"Yang W, Bancroft L, Augenlicht LH. Methylation in the p21(WAF1\/cip1) promoter of Apc(+\/\u2212), p21(+\/\u2212) mice and lack of response to sulindac. Oncogene\u20082005; 24: 2104\u20139.","DOI":"10.1038\/sj.onc.1208444"},{"key":"2022061621193711300_B20","doi-asserted-by":"crossref","unstructured":"Fodde R, Edelmann W, Yang K, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A\u20081994; 91: 8969\u201373.","DOI":"10.1073\/pnas.91.19.8969"},{"key":"2022061621193711300_B21","doi-asserted-by":"crossref","unstructured":"Newmark HL, Lipkin M, Maheshwari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J Natl Cancer Inst\u20081990; 82: 491\u20136.","DOI":"10.1093\/jnci\/82.6.491"},{"key":"2022061621193711300_B22","doi-asserted-by":"crossref","unstructured":"Newmark HL, Lipkin M, Maheshwari N. Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). Am J Clin Nutr\u20081991; 54: 209\u201314S.","DOI":"10.1093\/ajcn\/54.1.209S"},{"key":"2022061621193711300_B23","unstructured":"Yang WC, Mathew J, Velcich A, et al. Targeted inactivation of the p21(WAF1\/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res\u20082001; 61: 565\u20139."},{"key":"2022061621193711300_B24","unstructured":"Yang K, Edelmann W, Fan K, et al. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Res\u20081998; 58: 5713\u20137."},{"key":"2022061621193711300_B25","unstructured":"Sleisenger MH, Fordtran JS. Gastrointestinal disease. 5th ed. Philadelphia: W.B. Saunders Company; 1993."},{"key":"2022061621193711300_B26","unstructured":"Goldberg Y, Nassif II, Pittas A, et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene\u20081996; 12: 893\u2013901."},{"key":"2022061621193711300_B27","doi-asserted-by":"crossref","unstructured":"Augenlicht LH, Velcich A, Klampfer L, et al. Application of gene expression profiling to colon cell maturation, transformation and chemoprevention. J Nutr\u20082003; 133: 2410\u20136S.","DOI":"10.1093\/jn\/133.7.2410S"},{"key":"2022061621193711300_B28","doi-asserted-by":"crossref","unstructured":"Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci U S A\u20081997; 94: 3308\u201313.","DOI":"10.1073\/pnas.94.7.3308"},{"key":"2022061621193711300_B29","doi-asserted-by":"crossref","unstructured":"Chang WL, Chapkin RS, Lupton JR. Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J Nutr\u20081998; 128: 491\u20137.","DOI":"10.1093\/jn\/128.3.491"},{"key":"2022061621193711300_B30","doi-asserted-by":"crossref","unstructured":"Reddy BS. Omega-3 fatty acids in colorectal cancer prevention. Int J Cancer\u20082004; 112: 1\u20137.","DOI":"10.1002\/ijc.20320"},{"key":"2022061621193711300_B31","unstructured":"Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res\u20082001; 61: 1927\u201333."},{"key":"2022061621193711300_B32","doi-asserted-by":"crossref","unstructured":"Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Annu Rev Nutr\u20081999; 19: 545\u201386.","DOI":"10.1146\/annurev.nutr.19.1.545"},{"key":"2022061621193711300_B33","doi-asserted-by":"crossref","unstructured":"Hong MY, Chapkin RS, Davidson LA, et al. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr Cancer\u20082003; 46: 44\u201351.","DOI":"10.1207\/S15327914NC4601_06"},{"key":"2022061621193711300_B34","doi-asserted-by":"crossref","unstructured":"Little J, Sharp L, Duthie S, Narayanan S. Colon cancer and genetic variation in folate metabolism: the clinical bottom line. J Nutr\u20082003; 133: 3758\u201366S.","DOI":"10.1093\/jn\/133.11.3758S"},{"key":"2022061621193711300_B35","doi-asserted-by":"crossref","unstructured":"Diergaarde B, van Geloof WL, van Muijen GN, Kok FJ, Kampman E. Dietary factors and the occurrence of truncating APC mutations in sporadic colon carcinomas: a Dutch population-based study. Carcinogenesis\u20082003; 24: 283\u201390.","DOI":"10.1093\/carcin\/24.2.283"},{"key":"2022061621193711300_B36","doi-asserted-by":"crossref","unstructured":"Slattery ML, Curtin K, Schaffer D, Anderson K, Samowitz W. Associations between family history of colorectal cancer and genetic alterations in tumors. Int J Cancer\u20082002; 97: 823\u20137.","DOI":"10.1002\/ijc.10148"},{"key":"2022061621193711300_B37","doi-asserted-by":"crossref","unstructured":"Fodde R, Smits R. Cancer biology. A matter of dosage. Science\u20082002; 298: 761\u20133.","DOI":"10.1126\/science.1077707"},{"key":"2022061621193711300_B38","doi-asserted-by":"crossref","unstructured":"Sancho E, Batlle E, Clevers H. Live and let die in the intestinal epithelium. Curr Opin Cell Biol\u20082003; 15: 763\u201370.","DOI":"10.1016\/j.ceb.2003.10.012"},{"key":"2022061621193711300_B39","doi-asserted-by":"crossref","unstructured":"Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev\u20082003; 17: 1709\u201313.","DOI":"10.1101\/gad.267103"},{"key":"2022061621193711300_B40","doi-asserted-by":"crossref","unstructured":"Batlle E, Henderson JT, Beghtel H, et al. \u03b2-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB\/ephrinB. Cell\u20082002; 111: 251\u201363.","DOI":"10.1016\/S0092-8674(02)01015-2"},{"key":"2022061621193711300_B41","doi-asserted-by":"crossref","unstructured":"van de Wetering M, Sancho E, Verweij C, et al. The \u03b2-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell\u20082002; 111: 241\u201350.","DOI":"10.1016\/S0092-8674(02)01014-0"},{"key":"2022061621193711300_B42","unstructured":"Mariadason JM, Bordonaro M, Aslam F, et al. Down-regulation of \u03b2-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res\u20082001; 61: 3465\u201371."},{"key":"2022061621193711300_B43","doi-asserted-by":"crossref","unstructured":"Kielman MF, Rindapaa M, Gaspar C, et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of \u03b2-catenin signaling. Nat Genet\u20082002; 32: 594\u2013605.","DOI":"10.1038\/ng1045"},{"key":"2022061621193711300_B44","doi-asserted-by":"crossref","unstructured":"Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science\u20082002; 295: 1726\u20139.","DOI":"10.1126\/science.1069094"},{"key":"2022061621193711300_B45","doi-asserted-by":"crossref","unstructured":"Yang W, Velcich A, Lozonschi I, et al. Inactivation of p21WAF1\/cip1 enhances intestinal tumor formation in Muc2\u2212\/\u2212 mice. Am J Pathol\u20082005; 166: 1239\u201346.","DOI":"10.1016\/S0002-9440(10)62342-5"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/20\/9363\/2868236\/9363-9368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/20\/9363\/2868236\/9363-9368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:29:25Z","timestamp":1655422165000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/20\/9363\/518667\/p27kip1-in-Intestinal-Tumorigenesis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,15]]},"references-count":45,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2005,10,17]]},"published-print":{"date-parts":[[2005,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-2113","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,15]]}}}